Jan 04, 2018
Interferon regulatory factor 2 binding protein like
The IRF2BPL gene is thought to be a transcriptional activator, may be an E3 ubiquitin ligase, and is expressed in many organs including the central nervous system. This gene has been associated with a condition called Neurodevelopmental Disorder with Regression, Abnormal Movements, Loss of Speech and Seizures (NEDAMSS) (Marcogliese et al., 2018).
Changes in the IRF2BPL gene were identified in two UDN participants (Marcogliese et al, 2018).
The changes identified in the UDN participants are as follows:
Participant 031, a 6-year-old male with developmental regression, hypotonia, difficulty controlling voluntary movements (limb and truncal ataxia), and lack of coordination was found to carry the following genetic change in the IRF2BPL gene:
Participant 044, a 20-year-old male with developmental regression, paralysis (spastic tetraplegia), and brain damage (cerebellar atrophy) was found to carry the following genetic change in the IRF2BPL gene:
Ongoing Research:
Foundations/Support Groups:
Scientific Publications:
Additional Information:
Interested in learning more about this gene or sharing what you know? Contact us!